CNS therapeutics drug screening (Athena/DuPont)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCNS therapeutics drug screening (Athena/DuPont)
Drug Alias NameCNS therapeutics drug screening (Athena/CombiChem)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElan Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDeltagen Research Laboratories LLCElan Pharmaceuticals IncBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A